IDO2 and depressive symptom measurement: The inflammation hypothesis of depression also supports the 5-HT hypothesis, as it highlights the involvement of increased expression of indoleamine 2,3-dioxygenase (a rate-limiting enzyme in the tryptophan-kynurenine metabolic pathway) and posits the inhibition of 5-HT reuptake would be effective for the treatment of depression [22].